5 papers in the library · 380 citations · publishing 1976-2015
Canadian Medical Association Journal September 8, 2015 Kenneth W. Tupper, Evan Wood, Richard Yensen et al. 189 citations
In clinical research settings around the world, renewed investigations are taking place on the use of psychedelic substances for treating illnesses such as addiction, depression, anxiety and posttraumatic stress disorder (PTSD). Since the termination of a period of research from the 1950s to the
Journal of Psychoactive Drugs October 1, 1985 Richard Yensen 20 citations
A review of the historical trends in LSD research clearly indicates that LSD and similar drugs are too powerful and unique in their psychological effects to be mistaken for and studied as just another group of psychotropic compounds. The importance of the theoretical understanding and expectations of the researchers in determining the subjective effects and results of LSD treatment is...
Journal of Psychedelic Drugs October 1, 1977 John Rhead, Robert A. Soskin, Ibrahim Turek et al. 25 citations
(1977). Psychedelic Drug (DPT)-Assisted Psychotherapy with Alcoholics: A Controlled Study. Journal of Psychedelic Drugs: Vol. 9, No. 4, pp. 287-300.
Journal of Psychedelic Drugs 1977 William A. Richards, John Rhead, Francesco B. Dileo et al. 95 citations
(1977). The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients. Journal of Psychedelic Drugs: Vol. 9, No. 1, pp. 1-10.
The Journal of Nervous and Mental Disease October 1, 1976 Richard Yensen, Francesco B. Di Leo, John Rhead et al. 51 citations
Ten neurotic patients (five males and five females) were treated over a period of 2 to 6 months (mean, 4.1) as outpatients. The study allowed for a maximum of 75 hours of psychotherapy (mean, 51.55 hours). During the course of treatment, two to four (mean, 3.5) administrations of MDA (3,4-methylenedioxyamphetamine) were employed as adjunctive aids in an effort to enhance the psychotherapeutic...